Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis

Multiple Sclerosis

Volumn 15, Issue 6, 2009, Pages 668-677

  Fisniku, L K ^a   Altmann, D R ^a,b   Cercignani, M ^c   Tozer, D J ^a   Chard, D T ^a   Jackson, J S ^a   Miszkiel, K A ^d   Schmierer, K ^a   Thompson, A J ^a   Miller, D H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^d NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Clinically isolated syndromes; Grey matter atrophy; Lesion load; Magnetization transfer ratio; Multiple sclerosis; White matter atrophy

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ATROPHY; CONTROLLED STUDY; EXPANDED DISABILITY STATUS SCALE; FEMALE; FUNCTIONAL ASSESSMENT; GRAY MATTER; HISTOGRAM; HUMAN; IMAGE DISPLAY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; WHITE MATTER;

ADULT; AGED; ATROPHY; BRAIN; DISABILITY EVALUATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NERVE FIBERS, MYELINATED; NEURONS; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS;

EID: 66149180584     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509103715     Document Type: Article

References (50)

1. Fisniku. LK, Brex. PA, Altmann, DR et al. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 2008; 131(Pt 3): 808-817.
2. Brex, PA, Ciccarelli, O, O'Riordan, JI, Sailer, M, Thompson, AJ, Miller, DH. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002; 346: 158-164.
3. Fisniku, LK, Chard, DT, Jackson, JS et al. Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol 2008; 64(3): 247-254.
4. Pirko, I, Lucchinetti, CF, Sriram, S Bakshi, R. Gray matter involvement in multiple sclerosis. Neurology 2007; 68: 634-642.
5. Fisher, E, Lee, JC, Nakamura, K, Rudick, RA. Gray matter atrophy in multiple sclerosis: A longitudinal study. Ann Neurol 2008; 64: 255-265.
6. Agosta, F, Rovaris, M, Pagani, E, Sormani, MP, Comi, G, Filippi, M. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Brain 2006; 129(Pt 10): 2620-2627.
7. Khaleeli, Z, Sastre-Garriga, J, Ciccarelli, O, Miller, DH, Thompson, AJ. Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 2007; 78: 1076-1082.
8. Bo, L, Vedeler, CA, Nyland, HI, Trapp, BD, Mork, SJ. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 2003; 62: 723-732.
9. Kutzelnigg, A, Lucchinetti, CF, Stadelmann, C. et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128(Pt 11): 2705-2712.
10. Gilmore, CP, Donaldson, I, Bo, L, Owens, T, Lowe, JS, Evangelou N. Regional variations in the extent and pattern of grey matter demyelination in Multiple Sclerosis: A comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord. J Neurol Neurosurg Psychiatry 2008; 80(2): 182-187.
11. Moll, NM, Rietsch, AM, Ransohoff, AJ et al. Cortical demyelination in PML and MS: Similarities and differences. Neurology 2008; 70: 336-343.
12. Vercellino, M, Plano, F, Votta, B, Mutani, R, Giordana, MT, Cavalla, P. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 2005; 64: 1101-1107.
13. Huitinga, I, Erkut ZA., van, BD, Swaab, DF. Impaired hypothalamus-pituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions. Ann Neurol 2004; 55: 37-45.
14. Cifelli, A, Arridge, M, Jezzard, P, Esiri, MM, Palace, J, Matthews, PM. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 2002; 52: 650-653.
15. Pomeroy, IM, Jordan, EK, Frank, JA, Matthews, PM, Esiri, MM. Diffuse cortical atrophy in a marmoset model of multiple sclerosis. Neurosci Lett 2008; 437: 121-124.
16. Khaleeli, Z, Cercignani, M, Audoin, B, Ciccarelli, O, Miller, DH, Thompson, AJ. Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability. Neuroimage 2007; 37: 253-261.
17. van Waesberghe, JH, Kamphorst, W, De Groot, CJ, et al. Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999; 46: 747-754.
18. Mottershead, JP, Schmierer, K, Clemence, M. et al. High field MRI correlates of myelin content and axonal density in multiple sclerosis-a post-mortem study of the spinal cord. J Neurol 2003; 250: 1293-1301.
19. Schmierer, K, Scaravilli, F, Altmann, DR, Barker, GJ, Miller, DH. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 2004; 56: 407-415.
20. Dousset, V, Grossman, RI, Ramer, KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis: Lesion characterization with magnetization transfer imaging. Radiology 1992; 182: 483-491.
21. Schmierer, K, Tozer, DJ, Scaravilli, F, et al. Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain. J Magn Reson Imaging 2007; 26: 41-51.
22. Gareau, PJ, Rutt, BK, Karlik, SJ, Mitchell, JR. Magnetization transfer and multicomponent T2 relaxation measurements with histopathologic correlation in an experimental model of MS. J Magn Reson Imaging 2000; 11: 586-595.
23. Fernando, KT, Tozer, DJ, Miszkiel, KA, et al. Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis. Brain 2005; 128(pt 12): 2911-2925.
24. Davies, GR, Ramio-Torrenta, L, Hadjiprocopis, A et al. Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2004; 75: 998-1002.
25. Audoin, B, Ranjeva, JP, Au Duong MV, et al. Voxel-based analysis of MTR images: A method to locate gray matter abnormalities in patients at the earliest stage of multiple sclerosis. J Magn Reson Imaging 2004; 20: 765-771.
26. Rovaris, M, Agosta, F, Sormani, MP, et al Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: A medium-term follow-up study. Brain 2003; 126(Pt 10): 2323-2332.
27. Ge, Y, Grossman, RI, Udupa, JK, Babb, JS, Kolson, DL, McGowan, JC. Magnetization transfer ratio histogram analysis of gray matter in relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 2001; 22: 470-475.
28. Santos, AC, Narayanan, S, De SN, et al Magnetization transfer can predict clinical evolution in patients with multiple sclerosis. J Neurol 2002; 249: 662-668.
29. Ramio-Torrenta, L, Sastre-Garriga, J, Ingle, GT, et al. Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: A tissue specific magnetisation transfer study. J Neurol Neurosurg Psychiatry 2006; 77: 40-45.
30. Zivadinov, R, De, MR, Nasuelli, D, et al MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis. Neuroradiology 2001; 43: 272-278.
31. Poser, CM, Paty, DW, Scheinberg, L, et al.New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
32. Lublin, FD, Reingold, SC. Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46: 907-911.
33. Kurtzke, JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
34. Fischer, JS, Rudick, RA, Cutter, GR, Reingold, SC. The Multiple Sclerosis Functional Composite Measure (MSFC): An integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler 1999; 5: 244-250.
35. Barker, GJ, Tofts, PS, Gass, A. An interleaved sequence for accurate and reproducible clinical measurement of magnetization transfer ratio. Magn Reson Imaging 1996; 14: 403-411.
36. Sailer, M, O'Riordan, JI, Thompson, AJ, et al. Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination. Neurology 1999; 52: 599-606.
37. Ashburner, J, Friston, KJ. Unified segmentation. Neuroimage 2005; 26: 839-851.
38. Chard, DT, Griffin, CM, Parker, GJ, Kapoor, R, Thompson, AJ, Miller, DH. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 2002; 125(Pt 2): 327-337.
39. Cutter, GR, Baier, ML, Rudick, RA. et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999; 122(Pt 5): 871-882.
40. Bo, L, Vedeler, CA, Nyland, H, Trapp, BD, Mork, SJ. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 2003; 9: 323-331.
41. Phillips, MD, Grossman, RI, Miki, Y, et al. Comparison of T2 lesion volume and magnetization transfer ratio histogram analysis and of atrophy and measures of lesion burden in patients with multiple sclerosis. AJNR Am J Neuroradiol 1998; 19: 1055-1060.
42. Davies, GR, Altmann, DR, Hadjiprocopis, A, et al. Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis. J Neurol 2005; 252: 1037-1044.
43. Fernando, KT, Tozer, DJ, Miszkiel, KA, et al. Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis. Brain 2005; 128(Pt 12): 2911-2925.
44. Rovaris, M, Judica, E, Sastre-Garriga, J, et al. Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis. Mult Scler 2008; 14(4): 455-464.
45. Filippi, M, Iannucci, G, Tortorella, C. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology 1999; 52: 588-594.
46. van Buchem, MA, McGowan, JC, Grossman, RI. Magnetization transfer histogram methodology: Its clinical and neuropsychological correlates. Neurology 1999; 53(Suppl. 3): S23-S28.
47. Geurts, JJ, Bo, L, Pouwels, PJ, Castelijns, JA, Polman, CH, Barkhof, F. Cortical lesions in multiple sclerosis: Combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol 2005; 26: 572-577.
48. Geurts, JJ, Blezer, EL, Vrenken, H, et al. Does high-field MR imaging improve cortical lesion detection in multiple sclerosis? J Neurol 2008; 255: 183-191.
49. Geurts. JJ, Pouwels. PJ, Uitdehaag, BM, Polman, CH, Barkhof, F, Casteijns, JA. Intracortical lesions in multiple sclerosis: Improved detection with 3D double inversion-recovery MR imaging. Radiology 2005; 236: 254-260.
50. Nelson, F, Poonawalla, AH, Hou, P, Huang, F, Wolinsky, JS, Narayana, PA. Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging. AJNR Am J Neuroradiol 2007; 28: 1645-1649.